Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study

BACKGROUND: Recombinant factor VIIa (rFVIIa) may be used for rapid hemostasis in life-threatening hemorrhage. In warfarin-associated intracerebral hemorrhage (wICH), FVIIa use is controversial and may carry significant thromboembolic risks. We compared incidence of baseline thromboembolic risk facto...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: H-Y, Chou Sherry, Xuemei, Cai, G, Konigsberg Rachael, M, Bresette Linda, V, Henderson Galen, A, Sorond Farzaneh, K, Feske Steven
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3538560/
https://ncbi.nlm.nih.gov/pubmed/23241423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-12-158
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars